Health Cor Management, L.P. Ngm Biopharmaceuticals Inc Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$9.97 - $20.28 $3.16 Million - $6.42 Million	-316,679 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $339,031 - $471,121	-25,900 Reduced 7.56%	316,679 $4.39 Million
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $4.3 Million - $5.69 Million	342,579 New	342,579 $5.02 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.